A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Recruiting · NCT06826196 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT06826196 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aldena Therapeutics | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre de Recherche Saint-Louis | Québec | Canada | 1 |
| Clinical Trial Research Institute | Thousand Oaks | United States | 1 |
| Dermatology Specialists of Spokane | Spokane | United States | 9 |
| Innovaderm | Montreal | Canada | 2 |
| Options Research Group | West Lafayette | United States | 3 |
| The Brigham and Women's Hospital | Boston | United States | 4 |
| The Centre for Clinical Trials | Oakville | Canada | 5 |